Delivery Order SPE2DB20D1100-SPE2DB24FD2F5
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$30K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,911.68, is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. It is a firm fixed-price delivery order contract with a completion date of February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $23,478.45 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) for the supply of GLATOPA 40 MG/ML syringes. The award has no set-aside designation. Amerisourcebergen Drug Corp holds a single-award indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company AmerisourceBergen Corporation. The $10,538.64 firm fixed price delivery order is for the supply of GLATOPA 40 MG/ML syringes, a specialty pharmaceutical product. The award has a performance period through March 26, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an...
This federal contract award, valued at $1,385.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of GLATOPA 40 MG/ML syringes. The $5,400.00 firm fixed-price delivery order has an ultimate completion date of April 22, 2024 and does not utilize any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of GLATOPA 20 MG/ML SYRINGE/ML, with a potential value of $1,577.13. The contract has a completion date of November 15, 2022 and was awarded on November 14, 2022. No set-aside designation was used. Amerisourcebergen Drug Corp,...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the delivery of GLATOPA 40 MG/ML SYRINGEML pharmaceutical products. The $3,600.00 firm fixed price delivery order has a completion date of December 20, 2023. Amerisourcebergen Drug Corporation has extensive experience as a prime contractor providing pharmaceuticals, medical supplies, and distribution services to...
This federal contract award, valued at $3,016.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of September 30, 2021. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Glatopa 20 mg/mL syringes. The contract is a delivery order valued at $4,281.50 with a completion date of June 9, 2022. The contract is a firm fixed-price arrangement and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., another for-profit pharmaceutical distribution...
This federal contract award is for the delivery of Glatopa 40 mg/ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,533.26 and was awarded on February 17, 2022, with a completion date of February 18, 2022. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...